Top cited articles
Time to first decision:
1 days*
Time to first decision with review:
44 days*
Acceptance to publication:
26 days*
Impact Factor:
8.8
Total content views:
376,933
Total Altmetric mentions:
5,855
Adapt or die: how the pandemic made the shift from EBM to EBM plus more urgent
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making
Patient-reported outcome measures (PROMs) as proof of treatment efficacy
Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review
The limits of shared decision making
Making care fit manifesto
Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance
Theory and practice of Bayesian and frequentist frameworks for network meta-analysis
Transparency of COVID-19 vaccine trials: decisions without data
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study
Shared decision-making as a method of care
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies
Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
Component network meta-analysis in a nutshell
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis